FDA
-
-
-
-
-
-
-
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
-
-
-
-
-
-
-
Co-Diagnostics develops ebola test strategy with CoSara joint venture
-
-
-
-
-
-
-
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
-
-
-
-
-
-
-
Co-Diagnostics expands South Asia territory to include four new markets
-
-
-
-
-
-
-
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
-
-
-
-
-
-
-
Co-Diagnostics Performs Analysis of Influenza Co-PrimersĀ® to Confirm Reactivity Against Flu A H3N2 Mutation
-
-
-
-
-
-
-
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
-
326,558 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

